In the lung cancer cells (A549 and H1299), WA pre-treatment suppressed cell adhesion, migration, and invasion by downregulating the expression of tumor growth factor beta 1 (TGFβ1) and tumor necrosis factor α (TNFα) expression as well as epithelial-mesenchymal transition (Behl et al., 2020). Here, TNF is linked to lung carcinoma.